Nout, Remi A.
Erasmus MC Cancer Institute,
Netherlands
2025 Rank: 64000
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 1935 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 64000 | 65206 |
| Total Cites | 3052 | 3437 |
| H-index | 31 | 32 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 74 | 81 |
| Number of Single+First+Last Authored Papers | 32 | 32 |
| Total Cites to Single+First+Last Authored Papers | 237 | 260 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1558 | 1659 |
| Ratio of Total Citations to Distinct Citing Papers | 1.96 | 2.07 |
| Self-Citation Percentage |
11.20%
|
|
Nout, Remi A.
Erasmus MC,
Netherlands
2024 Rank: 60477
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 1957 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 60477 | 56882 |
| Total Cites | 2630 | 3104 |
| H-index | 25 | 27 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 13 | 13 |
| Total Cites to Single+First Authored Papers | 115 | 121 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 241 | 262 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1389 | 1500 |
| Ratio of Total Citations to Distinct Citing Papers | 1.89 | 2.07 |
| Self-Citation Percentage |
15.27%
|
|
Nout, Remi A.
Erasmus MC Cancer Institute,
Netherlands
2023 Rank: 66452
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 2411 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 66452 | 66563 |
| Total Cites | 2421 | 2891 |
| H-index | 27 | 28 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 110 | 121 |
| Number of Single+First+Last Authored Papers | 26 | 26 |
| Total Cites to Single+First+Last Authored Papers | 204 | 243 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1326 | 1434 |
| Ratio of Total Citations to Distinct Citing Papers | 1.83 | 2.02 |
| Self-Citation Percentage |
16.26%
|
|
Nout, Remi A.
Erasmus MC Cancer Institute,
Netherlands
2022 Rank: 89332
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3395 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 89332 | 81734 |
| Total Cites | 1816 | 2159 |
| H-index | 23 | 24 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 99 | 113 |
| Number of Single+First+Last Authored Papers | 24 | 24 |
| Total Cites to Single+First+Last Authored Papers | 151 | 180 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1063 | 1151 |
| Ratio of Total Citations to Distinct Citing Papers | 1.71 | 1.88 |
| Self-Citation Percentage |
15.89%
|
|
Nout, Remi A.
Erasmus MC Cancer Institute,
Netherlands
2021 Rank: 103454
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3689 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 103454 | 99692 |
| Total Cites | 2223 | 2657 |
| H-index | 26 | 29 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 152 | 164 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 226 | 253 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1406 | 1545 |
| Ratio of Total Citations to Distinct Citing Papers | 1.58 | 1.72 |
| Self-Citation Percentage |
16.33%
|
|
Nout, Remi A.
Leiden University Medical Center - LUMC,
Netherlands
2020 Rank: 107113
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 3717 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 107113 | 104017 |
| Total Cites | 1331 | 1582 |
| H-index | 20 | 22 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 146 | 158 |
| Number of Single+First+Last Authored Papers | 16 | 16 |
| Total Cites to Single+First+Last Authored Papers | 197 | 215 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 859 | 950 |
| Ratio of Total Citations to Distinct Citing Papers | 1.55 | 1.67 |
| Self-Citation Percentage |
15.87%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.